-+ 0.00%
-+ 0.00%
-+ 0.00%

Kiniksa Pharmaceuticals Q4 Earnings Assessment

Benzinga·02/24/2026 12:34:06
Listen to the news

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q4 earnings results on Tuesday, February 24, 2026 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Kiniksa Pharmaceuticals missed estimated earnings by -51.43%, reporting an EPS of $0.17 versus an estimate of $0.35.

Revenue was up $79.59 million from the same period last year.

Previous Earnings Records

The company missed on EPS by $0.12 in the last quarter, resulting in a 5.2% drop share price change the following day.

Here's a look at Kiniksa Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.35 0.21 0.28 0.13
EPS Actual 0.23 0.23 0.11 -0.12
Revenue Estimate 166.84M 145.24M 131.71M 123.38M
Revenue Actual 180.85M 156.80M 137.78M 122.54M

To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.